Cobalamin in inflammation III — glutathionylcobalamin and methylcobalamin/adenosylcobalamin coenzymes: the sword in the stone? How cobalamin may directly regulate the nitric oxide synthases

References

• Peracchi M., Bamonti Catena F., Pomati M., et al. Human cobalamin deficiency: alterations in serum tumour necrosis factor‐α and epidermal growth factor. Eur J Haematol 2001; 67: 123–7
   PubMed Web of Science ®Google Scholar
• Scalabrino G., Corsi M. M., Veber D., et al. Cobalamin (vitamin B12) positively regulates interleukin‐6 levels in rat cerebrospinal fluid. J Neuro‐immunol 2002; 127: 37–43
   PubMedGoogle Scholar
• Scalabrino G., Mutti E., Veber D. Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency. Neurosci Lett 2006; 396: 153–8
   PubMed Web of Science ®Google Scholar
• Sakone T., Takada S., Kotani H., Tsunematsu T. Effects of methyl‐B12 on the in vitro immune functions of human T lymphocytes. J Clin Immunol 1982; 2: 101–9
   PubMedGoogle Scholar
• Tamura J., Kubota K., Murakami H., et al. Immunomodulation by vitamin B12 augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin B12‐deficient patients by methyl‐B12 treatment. Clin Exp Immunol 1999; 116: 28–32
   PubMed Web of Science ®Google Scholar
• Wheatley C. A Scarlet Pimpernel for the resolution of inflammation? The role of supra‐therapeutic doses of cobalamin, in the treatment of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis, and septic or traumatic shock. Med Hypotheses 2006; 67: 124–42
   PubMedGoogle Scholar
• Wheatley C. The return of the Scarlet Pimpernel. Cobalamin in inflammation II: cobalamins can both selectively promote all three nitric oxide synthases (NOS), particularly iNOS and eNOS, and, as needed, selectively inhibit iNOS and nNOS. J Nutr Environ Med 2007; 16: 181–211
   PubMedGoogle Scholar
• Rachmilewitz D., Ligumsky M., Rachmilewitz B., et al. Transcobalamin II level in peripheral blood monocytes – a biochemical marker in inflammatory diseases of the bowel. Gastroenterology 1980; 78: 43–6
   PubMedGoogle Scholar
• Ling C. T., Chow B. F. Effect of vitamin B12 on the levels of soluble sulfhydryl compounds in blood. J Biol Chem 1953; 202: 445–56
   PubMedGoogle Scholar
• Register U. D. The effect of vitamin B12 on liver and blood non‐protein sulfhydryl compounds. J Biol Chem 1954; 206: 705–9
   PubMedGoogle Scholar
• Xia L., Cregan A. G., Berben L. A., Brasch N. E. Studies on the formation of glutathionylcobalamin: any free intracellular aquacobalamin is likely to be rapidly and irreversibly converted to glutathionylcobalamin. Inorg Chem 2004; 43: 6848–57
   PubMed Web of Science ®Google Scholar
• Suto R. K., Brasch N. E., Anderson O. P., Finke R. G. Synthesis, characterization, solution stability and X‐ray crystal structure of the thiolatocobalamin γ‐glutamylcysteinylcobalamin, a dipeptide analog of glutathionylcobalamin: insights into the enhanced Co‐S bond stability of the natural product glutathionylcobalamin. Inorg Chem 2001; 40: 2686–92
   PubMed Web of Science ®Google Scholar
• Dubnoff J. W., Bartron E. The effect of B12 on enzyme activity in E. coli mutant 113‐3. Arch Biochem Biophys 1956; 61: 99–110
   PubMedGoogle Scholar
• Pezacka E., Green R., Jacobsen D. W. Glutathionylcobalamin as an intermediate in the formation of cobalamin coenzymes. Biochem Biophys Res Comm 1990; 169((2))443–50
   PubMedGoogle Scholar
• Stamler J. S., Singel D. J., Loscalzo J. Biochemistry of nitric oxide and its redox activated forms. Science 1992; 258: 1898–902
   PubMed Web of Science ®Google Scholar
• Stamler J. S., Jaraki O., Osborne J., et al. Nitric oxide circulates in mammalian plasma primarily as an s‐nitroso adduct of serum albumin. Proc Natl Acad Sci 1992; 89: 7674–7
   PubMed Web of Science ®Google Scholar
• Singh S. P., Wishnok J. S., Keshive M., Deen W. M., Tannenbaum S. R. The chemistry of the s‐nitroso‐glutathione/glutathione system. Proc Natl Acad Sci 1996; 93: 14428–33
   PubMed Web of Science ®Google Scholar
• Ji Y., Akerboom T. P. M., Sies H., Thomas J. A. S‐Nitrosylation and S‐glutathionylation of protein sulfhydryls by S‐nitroso glutathione. Arch Biochem Biophys 1999; 362: 67–78
   PubMed Web of Science ®Google Scholar
• Zheng D., Birke R. L. The reaction of nitric oxide with glutathionylcobalamin. J Am Chem Soc 2002; 124: 9066–7
   PubMedGoogle Scholar
• Luschinsky Drennan C., Huang S., Drummond J. T., Matthews R. G., Ludwig M. L. How a protein binds B12: a 3.0Å X‐ray structure of B12‐binding domains of methionine synthase. Science 1994; 266: 1669–74
   PubMedGoogle Scholar
• Mancia F., Keep N. H., Nakagawa A., et al. How coenzyme B12 radicals are generated: the crystal structure of methylmalonyl‐coenzyme A mutase at 2Å resolution. Structure 1996; 4((3))339–49
   PubMedGoogle Scholar
• Zheng D., Yan L., Birke R. L. Electrochemical and spectral studies of the reactions of aquacobalamin with nitric oxide and nitrite ion. Inorg Chem 2003; 41: 2548–55
   Google Scholar
• Riches DWH., Underwood GA. Expression of interferon‐beta during the triggering phase of macrophage cytocidal activation. J Biol Chem 1991; 266: 24785–92
   PubMedGoogle Scholar
• Crane B. R., Arvai A. S., Gachui R., et al. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 1997; 278: 425–31
   PubMed Web of Science ®Google Scholar
• Crane B. R., Arvai A. S., Ghosh D. K., et al. Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 1998; 279: 2121–6
   PubMed Web of Science ®Google Scholar
• Fischmann T. O., Hruza A., Niu X. D., et al. Structural characterization of nitric oxide synthase isoforms reveals striking active‐site conservation. Nat Struct Biol 1999; 6: 233–42
   PubMedGoogle Scholar
• Li H., Raman C. S., Glaser C. B., et al. Crystal structures of zinc‐free and ‐bound heme domain of human inducible nitric oxide synthase. Implications for dimer stability and comparison with endothelial nitric oxide synthase. J Biol Chem 1999; 274: 21276–84
   PubMedGoogle Scholar
• Raman C. S., Li H., Martasek P., Kral V., Masters B. S., Poulos T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998; 95: 939–50
   PubMed Web of Science ®Google Scholar
• Tierney D. L., Huang H., Martasek P., et al. ENDOR studies of l‐arginine and N‐G‐hydroxyl‐l‐arginine bound to all three holo‐nitric oxide synthase isoenzymes. J Am Chem Soc 2000; 122: 5405–6
   Google Scholar
• Alderton W. K., Cooper C. E., Knowles R. G. Nitric oxide synthases: structure, function, and inhibition. Biochem J 2001; 357: 593–615
   PubMed Web of Science ®Google Scholar
• Salerno J. C., Harris D. E., Irizarry K., et al. An autoinhibitory control element defines calcium‐regulated isoforms of nitric oxide synthase. J Biol Chem 1997; 272: 29769–29777
   PubMed Web of Science ®Google Scholar
• Martásek P., Miller R. T., Roman L. J., Shea T., Masters B. S. S. Assays of isoforms of E. coli‐expressed nitric oxide synthase. Meth Enzymol 1999; 301: 70–8
   PubMedGoogle Scholar
• Raman C. S., Li H., Martasek P., Kral V., Masters B. S., Poulos T. L. Crystal structure of constitutive endothelial nitric oxide synthase: a paradigm for pterin function involving a novel metal center. Cell 1998; 95: 939–50
   PubMed Web of Science ®Google Scholar
• Albakri Q. A., Stuehr D. J. Intracellular assembly of inducible NO synthase is limited by nitric oxide – mediated changes in heme insertion and availability. J Biol Chem 1996; 271((10))5414–21
   PubMedGoogle Scholar
• Sennequier N., Wolan D., Stuehr D. J. Antifungal imidazoles block assembly of inducible NO synthase into an active dimer. J Biol Chem 1999; 274: 930–8
   PubMedGoogle Scholar
• McMillan K., Adler M., Auld D. S., et al. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry. Proc Natl Acad Sci 2000; 97: 1506–11
   PubMed Web of Science ®Google Scholar
• Berka V., Chen P. F., Tsai A. L. Spatial relationship between l‐arginine and heme binding sites of endothelial nitric‐oxide synthase. J Biol Chem 1996; 271: 33293–3300
   PubMed Web of Science ®Google Scholar
• Chabin R. M., McCauley E., Calaycay J. R., et al. Active‐site structure analysis of recombinant human inducible nitric oxide synthase using imidazole. Biochemistry 1996; 35: 9567–75
   PubMed Web of Science ®Google Scholar
• Wolff D. J., Datto G. A., Samatovicz R. A., Tempsick R. A. Calmodulin‐dependent nitric‐oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem 1993; 268: 9425–9
   PubMedGoogle Scholar
• Groves J. T., Wang C. C‐Y. Nitric oxide synthase: models and mechanisms. Curr Opin Chem Biol 2000; 4: 687–95
   PubMed Web of Science ®Google Scholar
• Swanson R. A., Dus K. M. Specific covalent labeling of cytochrome P‐450CAM with 1‐(4‐azidophenyl)imidazole, an inhibitor‐derived photoaffinity probe for P‐450 heme proteins. J Biol Chem 1979; 254: 7238–46
   PubMedGoogle Scholar
• Roman L. J., Martasek P., Miller T. R., et al. The C termini of constitutive nitric oxide synthases control electron flow through the flavin and heme domains and affect modulation by calmodulin. J Biol Chem 2000; 275: 29225–32
   PubMed Web of Science ®Google Scholar
• Masters B. S. Structural variations to accommodate functional themes of the isoforms of NO synthases. Nitric oxide: biology and pathobiology, L. J Ignarro. Academic Press, San Diego 2000; 91–104
   Google Scholar
• Sirovatka J. M., Finke R. G. Coenzyme B12 chemical precedent studies: probing the role of the imidazole base‐on motif found in B12‐dependent methylmalonyl‐CoA mutase. J Am Chem Soc 1997; 119: 3057–67
   Google Scholar
• Gruber K., Jogl G., Klintschar G., Kratky C. High resolution crystal structures of cobalamins. Vitamin B12 and B12 proteins, B Kräutler, D Arigoni, B. T Golding. Wiley, Weinheim 1999; 335–47
   Google Scholar
• Scheuring E. M., Sagi I., Chance M. R. Sulfur‐containing cobalamins: x‐ray absorption spectroscopic characterization. Biochemistry 1994; 33: 6310–5
   PubMedGoogle Scholar
• Couture M., Stuehr D. J., Rousseau D. L. The ferrous dioxygen complex of the oxygenase domain of neuronal nitric oxide synthase. J Biol Chem 2000; 275: 3102–205
   Google Scholar
• Marletta M. A., Hurshman A. R., Rusche K. M. Catalysis by nitric oxide synthase. Curr Opin Chem Biol 1998; 2: 656–63
   PubMed Web of Science ®Google Scholar
• Perry J. M., Marletta M. A. Effects of transition metals on nitric oxide synthase catalysis. Proc Natl Acad Sci 1998; 95: 11101–6
   PubMed Web of Science ®Google Scholar
• Kolb‐Bachofen V., Kröncke K‐D., Fehsel K., Suschek C. Role of inducible nitric oxide synthase in autoimmune or other immune‐mediated diseases. Nitric oxide: biology and pathobiology, L. J Ignarro. Academic Press, San Diego 2000; 811–21
   Google Scholar
• Alderton W. K., Boyham A., Lowe P. N. Nitroarginine and tetrahydrobiopterin binding to the haem domain of neuronal nitric oxide synthase using a scintillation proximity assay. Biochem J 1998; 332: 195–201
   PubMedGoogle Scholar
• Gardner P. R. Nitric oxide dioxygenase function and mechanism of flavohemoglobin, hemoglobin, myoglobin and their associated reductases. J Inorg Biochem 2005; 99((1))247–66
   PubMedGoogle Scholar
• Helmick R. A., Fletcher A. E., Gardner A. M., et al. Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin. AAC 2005; 49((5))1837–43
   Google Scholar
• Yamashiki M., Nishimura A., Kosaka Y. Effects of methylcobalamin (vitamin B12) on in vitro cytokine production of peripheral blood mononuclear cells. J Clin Lab Immunol 1992; 37: 173–82
   PubMedGoogle Scholar
• Bradbury D., Clarke D., Seedhouse C., Corbett C., Stocks J., Knox A. Vascular endothelial growth factor induction by prostaglandin E2 in human airway smooth muscle cells is mediated by E prostanoid EP2/EP4 receptors and SpI transcription factor binding sites. J Biol Chem 2005; 280: 29993–30000
   PubMedGoogle Scholar
• Bauer J., Morrison B. H., Grane R., et al. Effects of interferon β on transcobalamin II‐receptor expression and anti‐tumor activity of nitrosylcobalamin. J Natl Cancer Inst 2002; 94((13))1010–9
   PubMedGoogle Scholar
• Poydock M. Inhibiting effect of vitamins C and B12 on the mitotic activity of ascites tumours. Exp Cell Biol 1979; 47: 210–7
   PubMedGoogle Scholar
• Poydock M. E., Harguindey S., Hart T., Takita H., Kelly D. Mitogenic inhibition and effect of survival of mice bearing L1Z10 leukemia using a combination of dehydroascorbic acid and hydroxocobalamin. Am J Clin Oncol 1985; 8: 266–9
   PubMedGoogle Scholar
• Nishizawa Y., Yamamoto T., Terada N., et al. Effects of methylcobalamin on the proliferation of androgen‐sensitive or estrogen‐sensitive malignant cells in culture and in vivo. Int J Vitam Nutr Res 1997; 67: 164–70
   PubMedGoogle Scholar
• Tsao C., Miyashita K., Yang M. Cytotoxic activity of cobalamin in cultured malignant cells. Pathobiology 1990; 58: 292–6
   PubMedGoogle Scholar
• Bodian M. Neuroblastoma. Pediatr Clin North Am 1959; 6: 449–72
   Google Scholar
• Wheatley C. Multiple myeloma: the case of the .005% survivor. Living proof, M Gearin‐Tosh. Simon and Schuster, London 2002
   Google Scholar
• Wheatley C. A unified theory of the causes of monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma, with a consequent treatment proposal for long‐term control and possible cure. J Ortho Med 2002; 1: 7–16
   Google Scholar
• T. Cruz, A. Pastrak. Combination therapies using vitamin B12 and therapeutic agents for treatment of viral, proliferative and inflammatory disease. US Patent Application., Pub no. US2005/0163751 A1
   Google Scholar